PERSPECTA

News from every angle

Back to headlines

Piper Sandler Cuts Amphastar Pharmaceuticals Price Target Amid Uncertainty

Piper Sandler has cut its price target for Amphastar Pharmaceuticals, Inc. to $21, citing pipeline uncertainty, while also raising the price target for Unity Software.

2 Jun, 13:05 — 2 Jun, 13:05
PostShare

Sources

Showing 1 of 2 sources